Cholestasis induced antinociception and decreased gene expression of MOR1 in rat brain

Neuroscience

Volumn 284, Issue , 2015, Pages 78-86

  Ahmadi, S ^a   Karami, Z ^a   Mohammadian, A ^a   Khosrobakhsh, F ^a   Rostamzadeh, J ^a  

^a UNIVERSITY OF KURDISTAN   (Iran)

Author keywords

Antinociception; Cholestasis; Gene expression; Semi quantitative RT PCR

Indexed keywords

MU OPIATE RECEPTOR; NALOXONE; MESSENGER RNA; NARCOTIC ANTAGONIST; OPRM1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BILE DUCT LIGATION; BRAIN; CHOLESTASIS; CONTROLLED STUDY; CORPUS STRIATUM; GENE; GENE EXPRESSION; HIPPOCAMPUS; HOT PLATE TEST; HYPOTHALAMUS; LAPAROTOMY; MALE; MOR1 GENE; NEUROPATHOLOGY; NONHUMAN; PAIN ASSESSMENT; PREFRONTAL CORTEX; PRURITUS; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADVERSE EFFECTS; ANALYSIS OF VARIANCE; ANIMAL; BILE DUCT DISEASES; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PAIN; PAIN MEASUREMENT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; BILE DUCT DISEASES; BRAIN; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; LAPAROTOMY; MALE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN; PAIN MEASUREMENT; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; RNA, MESSENGER; TIME FACTORS;

EID: 84908292539     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.08.063     Document Type: Article

References (40)

1. Alemi F., Kwon E., Poole D.P., Lieu T., Lyo V., Cattaruzza F., Cevikbas F., Steinhoff M., Nassini R., Materazzi S., Guerrero-Alba R., Valdez-Morales E., Cottrell G.S., Schoonjans K., Geppetti P., Vanner S.J., Bunnett N.W., Corvera C.U. The TGR5 receptor mediates bile acid-induced itch and analgesia. J Clin Invest 2013, 123:1513-1530.
2. Almeida T.F., Roizenblatt S., Tufik S. Afferent pain pathways: a neuroanatomical review. Brain Res 2004, 1000:40-56.
3. Bergasa N.V., Alling D.W., Vergalla J., Jones E.A. Cholestasis in the male rat is associated with naloxone-reversible antinociception. J Hepatol 1994, 20:85-90.
4. Bergasa N.V., Rothman R.B., Vergalla J., Xu H., Swain M.G., Jones E.A. Central mu-opioid receptors are down-regulated in a rat model of cholestasis. J Hepatol 1992, 15:220-224.
5. Bergasa N.V., Sabol S.L., Young W.S., Kleiner D.E., Jones E.A. Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver. Am J Physiol 1995, 268:G346-G354.
6. Bhargava H.N., Gulati A. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats. Eur J Pharmacol 1990, 190:305-311.
7. Bunchorntavakul C., Reddy K.R. Pruritus in chronic cholestatic liver disease. Clin Liver Dis 2013, 16:331-346.
8. Carr F.B., Geranton S.M., Hunt S.P. Descending controls modulate inflammatory joint pain and regulate CXC chemokine and iNOS expression in the dorsal horn. Mol Pain 2014, 10:39.
9. Chiu K., Lau W.M., Lau H.T., So K.F., Chang R.C. Micro-dissection of rat brain for RNA or protein extraction from specific brain region. J Vis Exp 2007, 269.
10. Davis M. Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics. Clin Pharmacokinet 2007, 46:825-850.
11. Dogrul A., Ossipov M.H., Porreca F. Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors. Brain Res 2009, 1280:52-59.
12. Garcia-Ayllon M.S., Cauli O., Silveyra M.X., Rodrigo R., Candela A., Compan A., Jover R., Perez-Mateo M., Martinez S., Felipo V., Saez-Valero J. Brain cholinergic impairment in liver failure. Brain 2008, 131:2946-2956.
13. George O., Koob G.F. Individual differences in prefrontal cortex function and the transition from drug use to drug dependence. Neurosci Biobehav Rev 2010, 35:232-247.
14. Georgiev P., Jochum W., Heinrich S., Jang J.H., Nocito A., Dahm F., Clavien P.A. Characterization of time-related changes after experimental bile duct ligation. Br J Surg 2008, 95:646-656.
15. Ikemoto S. Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory. Neurosci Biobehav Rev 2010, 35:129-150.
16. Ikoma A., Rukwied R., Stander S., Steinhoff M., Miyachi Y., Schmelz M. Neurophysiology of pruritus: interaction of itch and pain. Arch Dermatol 2003, 139:1475-1478.
17. Jones E.A., Bergasa N.V. The pruritus of cholestasis. Hepatology 1999, 29:1003-1006.
18. Keil G.J., Delander G.E. Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors. J Pharmacol Exp Ther 1995, 274:1387-1392.
19. Le Marec T., Marie-Claire C., Noble F., Marie N. Chronic and intermittent morphine treatment differently regulates opioid and dopamine systems: a role in locomotor sensitization. Psychopharmacology (Berl) 2011, 216:297-303.
20. Lonsdale-Eccles A.A., Carmichael A.J. Opioid antagonist for pruritus of cholestasis unmasking bony metastases. Acta Derm Venereol 2009, 89:90.
21. Lozeva V., Montgomery J.A., Tuomisto L., Rocheleau B., Pannunzio M., Huet P.M., Butterworth R.F. Increased brain serotonin turnover correlates with the degree of shunting and hyperammonemia in rats following variable portal vein stenosis. J Hepatol 2004, 40:742-748.
22. Magen I., Avraham Y., Ackerman Z., Vorobiev L., Mechoulam R., Berry E.M. Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation. J Hepatol 2009, 51:528-534.
23. Magen I., Avraham Y., Ackerman Z., Vorobiev L., Mechoulam R., Berry E.M. Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation. Br J Pharmacol 2010, 159:950-957.
24. Marone M., Mozzetti S., De Ritis D., Pierelli L., Scambia G. Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample. Biol Proced Online 2001, 3:19-25.
25. Millan M.J. The induction of pain: an integrative review. Prog Neurobiol 1999, 57:1-164.
26. Moser H.R., Giesler G.J. Itch and analgesia resulting from intrathecal application of morphine: contrasting effects on different populations of trigeminothalamic tract neurons. J Neurosci 2013, 33:6093-6101.
27. Nelson L., Vergnolle N., D'Mello C., Chapman K., Le T., Swain M.G. Endogenous opioid-mediated antinociception in cholestatic mice is peripherally, not centrally, mediated. J Hepatol 2006, 44:1141-1149.
28. Neugebauer V., Galhardo V., Maione S., Mackey S.C. Forebrain pain mechanisms. Brain Res Rev 2009, 60:226-242.
29. Nicoll J., Axiotis C.A., Bergasa N.V. The delta opioid receptor 1 is expressed by proliferating bile ductules in rats with cholestasis: implications for the study of liver regeneration and malignant transformation of biliary epithelium. Med Hypotheses 2005, 65:1099-1105.
30. Noguchi H., Yamada S., Nabeshima A., Guo X., Tanimoto A., Wang K.Y., Kitada S., Tasaki T., Takama T., Shimajiri S., Horlad H., Komohara Y., Izumi H., Kohno K., Ichijo H., Sasaguri Y. Depletion of apoptosis signal-regulating kinase 1 prevents bile duct ligation-induced neuroinflammation and subsequent peribiliary fibrosis. Am J Pathol 2014, 184:644-661.
31. Ohsawa M., Mizoguchi H., Narita M., Chu M., Nagase H., Tseng L.F. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse. J Pharmacol Exp Ther 2000, 294:1106-1111.
32. Okuse K. Pain signalling pathways: from cytokines to ion channels. Int J Biochem Cell Biol 2007, 39:490-496.
33. Ossipov M.H., Harris S., Lloyd P., Messineo E., Lin B.S., Bagley J. Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy. Anesthesiology 1990, 73:1227-1235.
34. Ozdemir E., Gursoy S., Bagcivan I. The effects of serotonin/norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats. J Physiol Sci 2012, 62:317-323.
35. Rodriguez-Garay E.A. Cholestasis: human disease and experimental animal models. Ann Hepatol 2003, 2:150-158.
36. Rozeske R.R., Der-Avakian A., Bland S.T., Beckley J.T., Watkins L.R., Maier S.F. The medial prefrontal cortex regulates the differential expression of morphine-conditioned place preference following a single exposure to controllable or uncontrollable stress. Neuropsychopharmacology 2009, 34:834-843.
37. Seccareccia D., Gebara N. Pruritus in palliative care: getting up to scratch. Can Fam Physician 2011, 57(1010-1013):e1019-e1316.
38. Swain M.G., Rothman R.B., Xu H., Vergalla J., Bergasa N.V., Jones E.A. Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterology 1992, 103:630-635.
39. Trezza V., Damsteegt R., Achterberg E.J., Vanderschuren L.J. Nucleus accumbens mu-opioid receptors mediate social reward. J Neurosci 2011, 31:6362-6370.
40. Wright G., Soper R., Brooks H.F., Stadlbauer V., Vairappan B., Davies N.A., Andreola F., Hodges S., Moss R.F., Davies D.C., Jalan R. Role of aquaporin-4 in the development of brain oedema in liver failure. J Hepatol 2010, 53:91-97.